Paul Maffuid has been appointed executive vice president of operations at AAIPharma Services. Dr. Maffuid will have responsibility for the company’s drug product development services functions.

Dr. Maffuid has 27 years of pharmaceutical and biopharmaceutical product development experience. His oversight has included chemical and formulation development, manufacturing, analytical control functions and drug metabolism teams that successfully influenced the discovery and transition of therapeutics through clinical development and commercial launch.

Most recently, Dr. Maffuid served as president of Biopharmalogics, Inc., a provider of drug product consulting services to the life science industry. He has held leadership roles at Arena Pharmaceuticals, Amylin Pharmaceuticals, Magellan Laboratories, Cabrillo Laboratories and Glaxo Research Institute.

“AAIPharma Services is fortunate to have someone with Paul’s experience, expertise and vision to join our team,” said Pat Walsh, chief executive officer. “He will work closely with our leadership team and business groups in aligning our significant scientific Resources to better serve our clients.”